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Abstract: The purpose of this study was to investigate whether a nurse-led telephone session with patients suffering from 
breast cancer approximately ten days after final radiotherapy treatment affected their quality of life two to four weeks after 
radiotherapy. The study was conducted at the Radiotherapy ward at Vejle Hospital, Denmark between January and May 
2010. The study population consisted of 100 patients, who were randomized with a 1:1 ratio to have either ordinary 
supportive conversations (control group), or ordinary supportive conversations and a supplementary nurse-led telephone 
session (intervention group). The quality of life was assessed using the questionnaires EORTC QLQ-C30 and EORTC 
QLQ-BR23. For statistical comparison of quality of life and for adjustment for covariates, multiple linear regression 
analysis was conducted. The mean [95 % CI] quality of life was 72.0 [66.4-77.6] in the control group and 69.9 [64.3-75.2] 
in the intervention group. Adjustment for covariates did not change the estimates. No statistically significant differences 
were found in the groups in either of the analyses. The nurse-led telephone session had no positive effect on the quality of 
life of patients with breast cancer two to four weeks after their final radiotherapy. 
Keywords: Quality of life, breast neoplasm, questionnaire, RCT, supportive conversation, nursing, women. 
INTRODUCTION 
  Breast cancer is the most frequent type of cancer in 
Scandinavia, excluding skin cancer [1]. In 2008, the age 
standardized incidence rate of breast cancer in Scandinavia 
was 88.6/100,000 person years and the prevalence rate was 
1764/100,000 person years [2]. The main treatment for 
breast cancer is surgery followed by chemotherapy, 
radiotherapy, anti-hormones and/ or antibody treatment. 
  In Denmark, radiotherapy is ordinarily given daily five 
days a week for five to six weeks [3]. The treated women 
experience varying degrees of side effects of radiotherapy, 
such as skin burns, dyspnoea and malaise [4]. These side 
effects peak 10 to 14 days after the end of the treatment. 
Normally, the patients are not seen in the hospitals until six 
to 12 weeks after the end of the radiotherapy. American 
studies indicate that breast cancer patients feel vulnerable 
and insecure and express a need for follow-up, as they feel 
abandoned and have a poor quality of life [5, 6]. 
  Previous studies of quality of life among women with 
breast cancer have mainly focused on extended 
conversations and teaching sessions conducted by 
psychologists [7, 8]. To minimize costs, telephone sessions 
have been conducted [9, 10]. In a recent randomized study, 
Salonen et al. found no effect of a telephone session one 
week after surgery on quality of life, but the intervention   
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group had improvements concerning body image, future 
perspectives and side effects after surgery [11]. McArdle et 
al. found that a nurse-led telephone session induced 
decreased morbidity, e.g. less anxiety, insomnia and social 
dysfunction [12]. Interventions which had a total of less than 
20 hours of conversation had the greatest effect on quality of 
life, anxiety and depression according to a systematic review 
by Naaman et al. [13]. However, not all agree upon the 
efficiency of nurse-led interventions for women suffering 
from breast cancer. Wengstrom et al. found no effect of 
seven nurse sessions at 30 minutes each concerning quality 
of life in general and side effects, but they found that the 
intervention group had a reduced stress level compared to the 
control group [14]. 
 Efficace  et al. reported that baseline quality of life had an 
effect on survival in women with metastatic breast cancer 
[15], but others found diverging results [16, 17]. Debess et 
al. observed that women with breast cancer who had just 
finished their anti-hormone treatment or chemotherapy had a 
poorer quality of life compared to the control group of 
healthy women [18]. In the case of good quality of life 
enhancing life for severely ill people, there is a need for 
studies that improve the quality of life of women with breast 
cancer. 
  The present study aims to investigate whether one 
telephone session approximately ten days after the final 
radiotherapy treatment, with a nurse from the radiotherapy 
ward, where the information from the last session is 
repeated, affects the global quality of life for women with 
newly diagnosed primary breast cancer two to four weeks 32    The Open Nursing Journal, 2011, Volume 5  Høyer et al. 
after final radiotherapy treatment compared to the ordinary 
procedure without telephone sessions. 
MATERIALS AND METHODS 
Study Design 
  This was a single-center, parallel group study with 
balanced randomization (1:1) conducted in Denmark. 
Participants and Settings 
  Eligible participants were women 18 years or more with 
newly diagnosed primary breast cancer referred to the 
oncology ward at Vejle Hospital, Denmark for radiotherapy 
treatment, who had had either a lumpectomy or mastectomy, 
had access to a telephone, had sufficient hearing and spoke 
Danish. Exclusion criteria were prior breast cancer, prior or 
current serious illness, e.g. embolus or other cancers, or prior 
or current depression, dementia, anxiety or other psychiatric 
illness. One hundred patients were included in the study 
between January and May 2010. 
General Nursing Sessions for All Included Participants 
  All patients with breast cancer had either one or two 
sessions prior to and during radiotherapy treatment. Prior to 
treatment, a doctor and a nurse informed them of the effects 
and side effects of the performed surgery, former or future 
chemotherapy, anti-hormones, and the impending 
radiotherapy. Shortly before the end of the radiotherapy, all 
patients had a final session with a nurse relating to the 
radiotherapy period, side effects, treatment of side effects, 
medication during and after radiotherapy, mental state of 
mind, social conditions and prospective check-ups six to 
twelve weeks after radiotherapy. 
Intervention 
  Patients were randomly assigned either to receive a 
telephone session 10 days after the final radiotherapy or to 
have no contact with the Department of Oncology before the 
usual check-up six to 12 weeks after radiotherapy. The 
intervention was a telephone session which was conducted 
according to the same template as the last session prior to the 
final treatment. The nurse made sure to cover all the topics 
described above. The intervention was carried out by four 
experienced nurses who had between six and 20 years of 
oncology experience. The duration of the telephone sessions 
was 10 to 30 minutes. 
Outcome 
  The primary outcome concerned global quality of life. 
Secondary outcomes were side effects and specific 
symptoms. All patients included in the study rated the 
outcomes on the Danish version of the questionnaires 
EORTC QLQ-C30 and EORTC QLQ-BR23 two to four 
weeks after the final radiotherapy. This was four to 18 days 
after the telephone session in the intervention group. The 
questionnaires are developed by the European Organization 
for Research and Treatment of Cancer (EORTC), which is a 
group of European oncologists and researchers who have 
worked with cancer research since 1962. EORTC QLQ-C30 
is the global, cancer-specific questionnaire which is used to 
examine health-related quality of life among patients with 
cancer. The questionnaire was developed in 1993 and has 
been validated and revised several times [19]. The 
questionnaire is divided into five functional scales (physical, 
role, emotional, cognitive and social functioning) and nine 
symptom scales and single items (fatigue, nausea/vomiting, 
pain, dyspnoea, insomnia, appetite loss, constipation, 
diarrhea and financial difficulties). Side effects and specific 
symptoms among breast cancer patients were measured 
using EORTC QLQ-BR23 which is a supplement to EORTC 
QLQ-C30 developed in 1996. The questionnaire measures 
symptoms and side effects specifically among breast cancer 
patients [19]. The questionnaire is divided into five multi-
item scales and examines side effects, arm symptoms, breast 
symptoms, body image and sexual functioning. Furthermore, 
the questionnaire examines sexual pleasure, hair loss and 
future perspectives using single items [19]. 
  The responses were analyzed using the domains outlined 
in the scoring manual [20]. All scales and single items 
consisted of scales of either one to four or one to seven, and 
they were transformed into scores from one to 100. A high 
score meant a high response level; correspondingly, a high 
score in the functional scales meant a high level of function, 
a high score in global health meant a high self-rated health 
and quality of life, and high scores in the symptom scales 
meant a high level of symptoms [20]. 
Sample Size 
 No  similar study has found a difference in quality of life. 
To justify the study we wanted to detect a difference in 
quality of life of 10-15 percent points. To detect a difference 
in quality of life of 10.5 points (SD 18.5) with a two-sided 5 
% significance level and a power of 80 %, a sample of 49 
patients in each group was necessary. We set the study 
sample to 100 to allow for loss to follow-up. To recruit 100 
patients a three month period was anticipated. 
Randomization 
  For allocation of the participants, a computer-generated 
list of random numbers was used. A randomization sequence 
was created using the website www.random.org with a 1:1 
allocation using random block sizes of 10. The nurse who 
held the session with the patients at the end of the 
radiotherapy treatment performed the randomization. She 
was unaware of which intervention group the patient was 
allocated to. The patients were unaware of which group they 
were assigned to until they received either the telephone call 
or the questionnaire measuring quality of life. An 
investigator who was not otherwise involved in the project 
kept a log of the groups. 
Blinding 
  Patients became aware of which group they had been 
allocated to only at the time of the telephone call or when 
they received the questionnaire, whereas the data analyst was 
kept blinded to the allocation throughout. 
Statistical Analyses 
  Baseline characteristics of the two groups were compared by 
chi squared test for categorical data and unpaired t-test for 
continuous data. Quality of life data are presented as mean with 
95 % confidence intervals (95 % CI). A multiple linear 
regression was used to compare groups. Intention-to-treat 
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performed to assess whether protocol violation had influenced 
the result. In the per protocol analysis, any patients who should 
not have been included in the study, due to the inclusion criteria, 
were excluded. In the control group we excluded patients who 
had a telephone session or other types of sessions with health 
care providers. In the intervention group, we excluded patients 
who did not have a telephone session. 
  To determine whether a missing response had influenced the 
result, a sensitivity test was performed. A priori we decided that 
“type of operation”, “anti-hormone treatment” and “treatment” 
could be possible confounders and thus a multiple linear 
regression was conducted. Statistical differences with a p value 
 0.05 were considered statistically significant. Data were 
analyzed using Stata ™ 11.1. 
Ethics 
  All patients signed an informed consent form prior to 
participation. The study was authorized by the Danish Data 
Protection Agency, journal number 2009-41-3937. 
RESULTS 
  A total of 140 patients with breast cancer visited the 
radiotherapy ward during the study period. Fifteen patients 
were excluded due to the exclusion criteria, five patients did 
not fulfill the inclusion criteria and 20 patients did not want 
to participate for various reasons. In total, 100 patients were 
included, 50 in the intervention group and 50 in the control 
group. One patient in the intervention group was lost to 
follow-up due to failure to respond. The intervention group 
and the control group were quite homogeneous, but it was 
statistically significant that more women in the intervention 
group had a combination treatment in comparison with the 
control group (indicated by the variable “treatment”) and 
statistically significant that more women in the intervention 
group had anti-hormone treatment in comparison with the 
control group (indicated by the variable “anti-hormone 
treatment”). Most women had had a lumpectomy, had a short 
or medium long education and were married or cohabiting. 
 
Fig. (1). Flow diagram of a single center trial of nurse-led telephone session vs ordinary check-ups. The diagram includes detailed 
information on the excluded participants. * the same patient. 
Assessed for eligibility (n=140) 
Excluded (n=15) 
Did not meet inclusion criteria 
(n=5) 
Declined to participate (n=20) 
Patients randomized (n=100) 
Allocated to telephone session (n=50)  
Received telephone session (n=45) 
Did not receive telephone session (n=5) 
(1 did not answer telephone) 
(3 had mental illness or other cancer) 
(1 did not answer telephone and did not respond 
to questionnaire*) 
Allocated to ordinary check-ups 
(n=50) 
Received ordinary check-ups (n=50) 
Lost to follow-up (did not respond to  
questionnaire*) (n=1) 
Lost to follow-up (n=0) 
 
Included in intention-to-treat analysis (n=49)  
Excluded from per protocol analysis (n=4) (prior 
cancer=1, mental illness=2, did not answer 
telephone=1)  
Included in per protocol analysis (n=45) 
Included in intention-to-treat analysis 
(n=50)  
Excluded from the per protocol  
analysis (n=15) (prior cancer=3,  
had a telephone session/ contact  
with health care worker=12) 
Included in per protocol analysis 
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Mean age (SD) in the intervention group was 59 (9) years, 
and 61 (8) years in the control group (Table 1). 
  The primary analysis was intention-to-treat and included 
all patients who were randomly assigned and not lost to 
follow-up. Four patients in the intervention group and fifteen 
patients in the control group were protocol violators and thus 
80 patients were included in the per protocol analysis. 
  The mean (95 % CI) score of quality of life was 69.9 
(64.3; 75.2) in the intervention group and 72.0 (66.4; 77.6) in 
the control group. There was no statistically significant 
difference in quality of life between the groups. There was 
no statistically significant difference between the groups in 
the additional scales and items. Insomnia was borderline 
statistically significantly different between groups (p=0.06). 
The point estimates for insomnia were mean (95 % CI) 32.0 
(23.0; 41.0) in the intervention group and 20.0 (11.1; 28.9) in 
the control group (Table 2). The point estimates of 
constipation were mean 15.6 [9.6; 21.7] in the intervention 
group and 7.5 [1.5; 13.5] in the control group and was close 
to being statistically significantly different. 
  There were no statistically significant differences 
between the groups concerning side effects and symptoms. 
However, the point estimates for breast symptoms differed 
considerably. In the intervention group, the breast symptoms 
were mean 40.5 (34.4; 46.6) and in the control group, the 
breast symptoms were mean 34.6 (28.7; 40.6) (Table 3). 
  As a sub-analysis, a per protocol analysis was conducted. 
In this analysis, patients who were included by mistake and 
patients who did not receive the intended intervention were 
excluded. The estimates do not change in the per protocol 
analysis in comparison to the intention-to-treat analysis. The 
quality of life was mean 70.6 (64.6; 76.6) in the intervention 
group and 71.9 (65.1; 78.7) in the control group (Table 4). 
 
Table 1.  Clinical and Demographic Characteristics of the Study Population 
 
Intervention Group (n = 50)  Control Group (n = 50)  P 
59 (9)  61 (8)   0.22
*  Age Mean (SD) 
n =  (%)  n =  (%)   
Tumor stage
1 
T1 
T2 
T3 
Tis
 
Unknown 
 
27 
8 
0 
3 
12 
 
(54) 
(16) 
(0) 
(6) 
(24) 
 
24 
8 
1 
10 
7 
 
(48) 
(16) 
(2) 
(20) 
(14) 
 
0.18
^ 
 
Operation 
Lumpectomy 
Mastectomy 
Bilateral
2 
 
40 
9 
1 
 
(80) 
(18) 
(2) 
 
43 
7 
0  
 
(86) 
(14) 
(0) 
 
0.51
^ 
Chemotherapy 
Yes 
No 
Unknown  
 
21 
27 
2 
 
(42) 
(54) 
(4) 
 
15 
34 
1 
 
(30) 
(68) 
(2) 
 
0.34
^ 
 
Anti-hormone therapy 
Yes 
No 
Unknown 
 
31 
18 
1 
 
(62) 
(36) 
(2) 
 
18 
32 
0 
 
(36) 
(64) 
(0) 
 
0.02
^ 
Treatment 
Radiotherapy only 
Combination of treatments
3 
 
14 
36 
 
(28) 
(72) 
 
25 
25 
 
(50) 
(50) 
 
0.04
^ 
Civil status
# 
Married/cohabiting 
Single/widow  
 
42 
7 
 
(86) 
(14) 
 
38 
12 
 
(76) 
(24) 
 
0.22
^ 
Education
 # 
Primary school/High school 
Blue collar/College 
University  
Unknown 
 
15 
32 
1 
1  
 
(31) 
(65) 
(2) 
(2) 
 
12 
32 
4 
2 
 
(24) 
(64) 
(8) 
(4) 
 
0.36
^ 
#One missing patient in the intervention group. * P-value derived from an un-paired t-test. ^ P-value derived from a chi squared test. 
1Tumor classification according to AJCC Cancer Staging Manual [21]. 
2Bilateral= double-sided, here meaning that the patient had had a lumpectomy on one side and a mastectomy on the other side. 
3A combination of radiotherapy and chemotherapy and/or anti-hormone therapy. Telephone Session and Quality of Life  The Open Nursing Journal, 2011, Volume 5    35 
  Additionally, a multiple linear regression analysis was 
conducted, adjusting for the variables “treatment”, 
“operation” and “anti-hormone treatment”. The crude 
estimate of quality of life was mean 69.9 (64.3; 75.5) and the 
adjusted mean was 71.5 (63.1; 79.9) in the intervention 
group. In the control group, the crude mean (95 % CI) 
quality of life was 72.0 (66.4; 77.6) and the adjusted mean 
was 73.2 (66.2; 80.1). 
Table  2.  Quality of Life, Function and Symptom Scores from EORTC QLQ-C30 for the 99 Women who Responded to the 
Questionnaire. Intention-to-Treat Analysis 
 
Intervention Group (n=49)  Control Group (n=50) 
QLQ-C30 Sub-Scales 
 M  95 % CI   M  95 % CI 
P 
Global health status & quality of life  69.9  64.3; 75.2  72.0   66.4; 77.6  0.60 
Physical functioning  84.6  80.0; 89.2   86.0  81.5; 90.6  0.67 
Role functioning  75.5  68.4; 82.6  77.7  70.6; 84.7  0.67 
Emotional functioning  79.4  73.6; 85.3  80.8  75.0; 86.6  0.73 
Cognitive functioning  83.7  77.8; 89.6  85.3  79.5; 91.2  0.40 
Social functioning  88.4  83.2; 93.6  88.7  83.5; 93.8  0.95 
Fatigue  35.3  28.2; 42.3  31.3  24.4; 38.3   0.43 
Nausea and vomiting  7.8  2.7; 12.9  4.7  -0.4; 9.7  0.38 
Pain  21.4  14.7; 28.2  20.3  13.7; 27.0  0.82 
Dyspnea  14.3  7.9; 20.7  13.3  7.0; 19.6  0.83 
Insomnia  32.0  23.0; 41.0  20.0  11.1; 28.9  0.06 
Appetite loss  10.9  4.9; 16.9  7.3  1.4; 13.3  0.41 
Constipation
1  15.6  9.6; 21.7  7.5  1.5; 13.5  0.06 
Diarrhea  11.6  4.9; 18.3  9.3  2.7; 15.0  0.64 
Financial difficulties  4.8  -0.26; 9.8  6.0  1.0; 11.0  0.73 
M= mean. 95 % CI= 95 % confidence interval. P derived from multiple linear regression. 
1One patient missing in the control group. 
 
Table  3.  Function and Symptom Scores from EORTC QLQ-BR23 for the 99 Women Who Responded to the Questionnaire. 
Intention-to-Treat Analysis 
 
Intervention Group (n=49)  Control Group (n=50) 
QLQ- BR23 Subscales 
M  95 % CI  M  95 % CI 
P 
Body image
1)  80.6  74.6; 86.6  81.0  75.0; 87.0  0.95 
Sexual functioning
2)  19.4  13.6; 25.3  21.4  15.4; 27.3  0.76 
Sexual pleasure
3)  53.3  42.4; 64.3  62.1  51.6; 72.6  0.28 
Future perspective
1)  57.8  49.3; 66.3  59.2  50.7; 67.7  0.71 
Systematic therapy side effects   16.6   12.8; 20.3   16.3   12.6; 20.1  0.63 
Breast symptoms
4)   40.5   34.4; 46.6   34.6   28.7; 40.6   0.09 
Arm symptoms
5)   16.1   10.8; 21.4   14.7   9.5; 19.8   0.60 
Upset by hair loss
6)   6.9   0.87; 13.0   7.5   1.5; 13.5   0.78 
M=mean. 95 % CI= 95 % confidence interval. P derived from multiple linear regression. 
1)1 patient missing in the control group. 
2) 1 patient missing in the intervention group and 4 patients missing in the control group. 
3) Responses from patients who had been sexually 
active within the last week= 20 patients in the intervention group and 22 patients in the control group.
 4) 2 missing patients in the intervention group and 1 missing patient in the 
control group. 
5) 2 missing patients in the intervention group. 
6) 1 missing patient in each group. 
 
Table 4.  Global Health of the 80 Patients Who Had the Intended Intervention. Per Protocol Analysis 
 
Intervention Group (n=45)  Control Group (n=35) 
QLQ-C30 
M  95 % CI  M  95 % CI 
P 
Global health status & quality of life  70.6  64.6; 76.6  71.9  65.1; 78.7  0.77 
M=mean. 95 % CI= 95 % confidence interval. P derived using a linear regression. 36    The Open Nursing Journal, 2011, Volume 5  Høyer et al. 
  To assess whether one missing patient in the intervention 
group had influenced the result, a sensitivity analysis was 
performed on the poorest and the best possible response   
from the missing patient. The result of the sensitivity test 
indicated that the result was not influenced by the missing 
patient in the intervention group. 
DISCUSSION 
  This clinically controlled, randomized study found that a 
nurse-led telephone session with women treated for newly 
diagnosed primary breast cancer approximately ten days 
after the final radiotherapy had no significant effect on 
global quality of life measured as global health on the QLQ-
C30 scale two to four weeks after the final radiotherapy 
treatment. Furthermore, the telephone session had no effect 
on functional scales, symptom scales, multi-item scales or 
single-item scales measured on QLQ-BR23. The result might 
even suggest that the intervention may be harmful, as the 
control group had a better quality of life in comparison with 
the intervention group. 
  The intervention in this study was quite small which 
might have caused the lack of a statistically significant 
difference in quality of life between the groups. A study 
which matched this study concerning the intervention and 
duration of session performed by a physiotherapist, did not 
find a difference in quality of life either, but did identify an 
improved body image, fewer side effects and less concern 
about the future [11]. An earlier study of the quality of life 
among Danish women using the EORTC QLQ-C30 found a 
global health of mean (SD) 74.8 (23.8), which is a somewhat 
better result than we found in this study [22]. The better 
quality of life found in the study by Klee et al. is consistent 
with the fact that their study examined healthy women. The 
women in this study suffered more from fatigue, 
constipation, diarrhea and nausea but had fewer financial 
difficulties than the healthy women in the study by Klee et 
al., but otherwise the results are quite similar [22]. 
  Within quality of life research, a theory concerning 
“response shift” (a change in the meaning of people’s self-
evaluation) during chronic or severe illness has been 
developed [23]. Osborne et al. have argued that chronically 
ill people attending self-management programs feel either a 
negative response shift (people feel worse than before the 
program), no response shift (people feel about the same as 
prior to the program) or a positive response shift (people feel 
better than before the program) [24]. It is possible that the 
telephone session left the majority of patients in the 
intervention group with a negative response shift which 
could then be the reason that the patients in the intervention 
group did not report a higher quality of life than the patients 
in the control group. 
  The timing of the measurement of quality of life might be 
of significance to the response, and it is possible that two 
weeks after the final treatment is not the time where the 
intervention causes a changed quality of life. A longer 
follow-up might give another result. 
  As the study is randomized, it is expected that all 
possible confounders are equally distributed in the 
intervention and control groups. A priori three covariates 
were identified as possible confounders. A multiple linear   
 
regression was conducted to adjust for potential confounding 
by these covariates. Crude and adjusted results did not differ 
notably, and thus confounding by these covariates was not 
likely. 
  The systematic review by Naaman et al. found that 
interventions with a total of less than 20 hours were 
moderately associated with better quality of life [13]. The 
intervention in this study was of approximately 10 to 30 
minutes and showed neither effect on quality of life nor any 
other measured variable. As the results concerning insomnia, 
constipation and breast symptoms in this study approached 
statistical significance contradicting the hypothesis, it is 
possible that the telephone session with information on the 
side effects actually induced symptoms that the women 
would not have felt had they not had a telephone session. 
  A limitation to this study was the fact that we did not 
assess quality of life at baseline. We assumed the baseline 
quality of life to be the same in the intervention group and 
the control group. If the baseline quality of life differed in 
the two groups, it is possible that the intervention did 
enhance the quality of life in the intervention group, but it is 
not possible to assess this change due to the design of this 
study. 
  Some women with breast cancer also suffer from co-
morbidity. These women were not investigated in this study 
and the result cannot be generalized to women with co-
morbidities. On the other hand, these results can be 
generalized broadly to radiotherapy wards treating similar 
women, as the women examined here were not specially 
selected. 
  It is possible that a change in the juncture of the 
intervention and the timing of the measurement of quality of 
life, as well as an intervention of a larger scale, would 
change the results. In the questionnaire, the women in the 
intervention group were asked to comment on the content 
and timing of the intervention. The majority of women were 
satisfied concerning both. A satisfaction survey might have 
found an association between the intervention and an 
improved degree of satisfaction. Coping is another outcome 
that might have found an association and further research 
needs to address these areas of interest. 
CONCLUSION 
  The study found no statistically significant effect of the 
telephone session on quality of life and function and 
symptom scores measured two to four weeks after the final 
radiotherapy treatment. Despite the limited study size, the 
point estimates indicate that telephone sessions were not 
associated with an improved quality of life, but perhaps with 
the opposite. 
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